The CMO's open-market sales of $4.51M across multiple trades within one day after derivative exercises could indicate a lack of near-term bullish conviction. Monitor for any upcoming regulatory or pipeline catalyst that may have been anticipated. No immediate trading catalyst, but the cluster should be acknowledged as a mild negative signal.
Price Chart
Executive Summary
A cluster of insider selling at Jazz Pharmaceuticals totals $6.01M in open-market sales over a 7-day window. The largest seller is the EVP of R&D and CMO, which could signal reduced conviction ahead of upcoming catalysts or data readouts. While the dollar value is modest at ~0.04% of the $15.8B market cap, the concentration in C-suite open-market sales rather than tax-withholding adds a mild bearish tilt.
Key Financial Metrics
Key Facts
- Total open-market sales: $6.01M by Director Bruce Cozadd ($1.50M) and EVP/CMO Robert Iannone ($4.51M in multiple trades)
- Cluster includes $1.6M in tax-withholding transactions (non-cash, no new economic signal) from directors Kennedy, McSharry, Winningham, and Cozadd
- C-suite open-market selling accounts for ~75% of the cluster's dollar value; director open-market selling accounts for ~25%
- Proportionality check: total open-market sales represent ~0.04% of market cap, below the 0.1% threshold for materiality, but the C-suite weighting elevates the signal slightly
Financial Impact
Total open-market selling of $6.01M, representing 0.04% of market cap; not a balance-sheet event for the company
Risk Factors
- Potential loss of confidence in near-term pipeline milestones or revenue growth trajectory
- If subsequent news disappoints, the insider selling pattern may be viewed as an informed move
- Tax-withholding transactions are routine and should not be extrapolated as negative signals
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-JAZZ-1788383088494 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $205.70 | awaiting T+1 | — | $206.20 (−0.24%) |
Oct 19, 2026 7d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $206.20 (−3.54%) |
Oct 9, 2026 18d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $206.20 (−5.59%) |
Oct 8, 2026 18d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $206.20 (−5.59%) |
Oct 6, 2026 20d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $206.20 (−10.81%) |
Oct 1, 2026 25d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $206.20 (−12.50%) |
Sep 15, 2026 6w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $206.20 (−14.38%) |
Sep 14, 2026 6w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $206.20 (−14.38%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $206.20 (−16.11%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $206.20 (+16.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers